DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $69.49, but opened at $76.08. DiaSorin shares last traded at $76.08, with a volume of 205 shares trading hands.
Wall Street Analyst Weigh In
Separately, Morgan Stanley raised DiaSorin from an “underweight” rating to an “overweight” rating in a research note on Tuesday, August 26th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, DiaSorin presently has a consensus rating of “Buy”.
View Our Latest Analysis on DSRLF
DiaSorin Price Performance
DiaSorin Company Profile
DiaSorin S.p.A. is an Italy‐based global biotechnology company specializing in the development, manufacture and marketing of in vitro diagnostic products. Headquartered in Saluggia, DiaSorin serves clinical laboratories, hospitals and physician offices with a broad portfolio of immunodiagnostic assays and molecular diagnostic tests. The company’s shares trade on the Milan Stock Exchange and are available in the United States as over‐the‐counter (OTC) securities under the symbol DSRLF.
At the core of DiaSorin’s business are immunodiagnostic systems that measure antibodies, antigens and hormones in human samples.
Featured Stories
- Five stocks we like better than DiaSorin
- The boring AI play that could pay up to $4,290 monthly
- The gift that keeps giving (just $1 today)
- The Best $1 You’ll Spend This Holiday Season
- Trump Did WHAT??
- Put $1,000 into this stock by Jan 1 [Not NVDA]
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.
